| Company/Division name | Royal Canin USA |
| Parent company | Mars Inc. |
| Type of work | Manufacturing |
| If manufacturing, is the company an OEM? | Yes |
| Reshoring category: | Transplant |
| Year reshoring announced: | 2016 |
| Year reshoring implemented or to be implemented: | 2019 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 100 |
| Country(ies) from which reshored: | France |
| City reshored to: | North Sioux City |
| State(s) reshored to: | ND |
| If relevant, work nearshored to: | - |
| Industry(ies): | Food & Beverage |
| Product(s) reshored | Pet Food |
| What domestic positive factors made reshoring more attractive? | Customer responsiveness improvement, Proximity to customers/market |
